Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Liver biopsy proved CHB and/or NAFLD at baseline;
• Chinese
• Follow-up duration\>12 months
Locations
Other Locations
China
Humanity and Health GI and Liver Centre
RECRUITING
Hong Kong
Contact Information
Primary
George Lau, MD
gkklau@netvigator.com
+852 2861 3777
Time Frame
Start Date: 2016-08-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 1500
Treatments
CHB Group
Patients with chronic hepatitis B
CHB/NAFLD Group
Patients with chronic hepatitis B and comorbid nonalcoholic fatty liver disease
NAFLD Group
Patients with nonalcoholic fatty liver disease
Related Therapeutic Areas
Sponsors
Leads: Humanity and Health Research Centre